Pulmonary fibrosis is the end point of a chronic inflammatory process
characterized by leukocyte recruitment and activation, fibroblast prol
iferation, and increased extracellular matrix production, Previous stu
dies of models of pulmonary fibrosis have investigated the role of cyt
okines in the evolution of the fibrotic response, The involvement of t
umor necrosis factor and interleukin-1 in bleomycin-induced lung injur
y, a model of idiopathic pulmonary fibrosis, has been well established
, suggesting that cytokines mediate the initiation and maintenance of
chronic inflammatory lesions, However, the aforementioned cytokines al
one cannot account for the recruitment and activation of specific leuk
ocyte populations found in the bleomycin model, Recently, a family of
novel proinflammatory cytokines (chemokines) was cloned and characteri
zed, yielding many putative mediators of leukocyte functions, Macropha
ge inflammatory protein-1 alpha (MIP-1 alpha) and monocyte chemoattrac
tant protein-1 (MCP 1) belong to the C-C chemotactic cytokine family,
a group of low-molecular-weight peptides, These molecules modulate che
motaxis, proliferation, and cytokine expression in leukocyte subsets,
Our group has investigated the roles of MCP-1 and MIP-1 alpha in the b
leomycin model, Both MCP-1 and MIP-1 alpha are expressed in a time-dep
endent manner after bleomycin challenge, and passive immunization of t
hese animals with either anti-MIP-1 alpha or anti-MCP-1 antibodies att
enuated leukocyte accumulation, In addition, we have identified specif
ic cell types expressing MCP-1 or MIP-1 alpha by in situ hybridization
and immunohistochemical localization, respectively, Furthermore, our
results indicate that MIP-1 alpha expression is mediated by alveolar m
acrophage-derived tumor necrosis factor, identifying an important cyto
kine pathway in the initiation of pulmonary fibrosis, Finally, anti-MI
P-1 alpha therapy attenuated fibrosis, providing direct evidence for i
ts involvement in fibrotic pathology, Our work has clearly established
that the C-C chemokines MCP-1 and MIP-1 alpha are expressed and contr
ibute to the initiation and maintenance of the bleomycin-induced pulmo
nary lesion.